A Study in Healthy Men to Test How BI 1265162 is Taken up and Processed by the Body

PHASE1

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped Due to the COVID-19 pandemic, the recruitment of new subjects was temporarily halted in March 2020. The study was permanently discontinued in December 2020.

Conditions

Healthy Volunteers

Interventions

DRUG: Part 1: BI 1265162 - intravenous
DRUG: Part 2: BI 1265162 - oral

Sponsor

Boehringer Ingelheim